Fieldview Capital Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$779K Sell
8,050
-30,194
-79% -$3.1M 0.23% 141
2025
Q4
$4.06M Buy
38,244
+2,347
+7% +$272K 0.69% 28
2025
Q3
$4.56M Buy
35,897
+8,871
+33% +$1.06M 0.75% 28
2025
Q2
$3.31M Sell
27,026
-18,566
-41% -$2.12M 0.5% 74
2025
Q1
$4.62M Sell
45,592
-2,119
-4% -$207K 0.65% 39
2024
Q4
$4.41M Buy
+47,711
New +$4.68M 0.68% 36

Other funds holding EHC

Fieldview Capital Management's EHC Position: Q1 2026 in Review

Fieldview Capital Management reduced its Encompass Health (EHC) stake by 79% in Q1 2026, selling an estimated $3.1M and leaving 8,050 shares worth $779K. The position accounts for 0.23% of the portfolio, ranked #141.

Fieldview Capital Management first reported a position in EHC in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.62M in Q1 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Fieldview Capital Management held 8,050 shares of Encompass Health worth $779K as of Q1 2026.
  • Fieldview Capital Management sold 30,194 Encompass Health shares in Q1 2026, an estimated $3.1M.
  • Encompass Health made up 0.23% of Fieldview Capital Management's portfolio in Q1 2026, its #141 holding.
  • Fieldview Capital Management first reported a position in Encompass Health in Q4 2024 and has held it in 6 quarters since.
  • Fieldview Capital Management's Encompass Health position peaked at $4.62M in Q1 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.